[Photo from LinkedIn]
Ganesh Mayya had spent more than three decades at the imaging giant, most recently as senior VP of software engineering across its CT, MRI, X-ray and women’s health portfolios, a position he has held since 2020. Prior to that, he served as chief technology officer for GE HealthCare’s global molecular imaging and CT business.
Mayya’s work at Edwards, sitting under its advanced innovation and technology division, will cover the digital capabilities of connected products, including embedded systems, cloud platforms and artificial intelligence.
“Edwards has transformed structural heart care through some truly remarkable innovations, and I am excited about what lies ahead as medical devices become increasingly connected, data-driven, and intelligent,” Mayya wrote in a post announcing the move this week on LinkedIn.
Related: GE HealthCare rolls out AI software for predicting care bottlenecks
“This role is also very personal for me,” he added. “I have always enjoyed building things, whether it is software, platforms, new capabilities, or teams. The opportunity to help build and shape Digital Product Engineering at Edwards, work alongside some incredibly talented people, and learn a completely new clinical domain is exactly the kind of challenge that energizes me.”
Edwards is seeking to build AI-enabled features into its structural heart portfolio, including potentially clinician-facing software that may require FDA clearance and a predetermined change control plan for delivering updates over time, according to company job postings.
At GE HealthCare, Mayya started in 1995 as a senior design engineer in Bangalore, India. He would later be based outside Milwaukee, as well as Chicago and Dallas, with roles including engineering director and general manager of global MRI software.
“Thirty-two years is a long time. It is difficult to put all the experiences, relationships, successes, failures, lessons, laughter, and memories into one post,” he wrote on LinkedIn. “I leave GE HealthCare with tremendous gratitude, pride, and respect. Most of all, I leave with lifelong relationships and memories that I will always cherish.”
Edwards’ previous critical care division — the main focus of its digital efforts, spanning AI, patient monitoring and connected sensors for operating rooms and intensive care — was sold to BD in 2024 for $4.2 billion.
